Obstetrical antiphospholipid syndrome: From the pathogenesis to the clinical and therapeutic implications

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Marchetti, T ^a   Cohen, M ^a   De Moerloose, P ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMALARIAL AGENT; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; STEROID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; APOPTOSIS; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DRUG TREATMENT FAILURE; ECLAMPSIA; FERTILIZATION IN VITRO; FETUS DEVELOPMENT; FETUS WASTAGE; HELLP SYNDROME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; LUNG EMBOLISM; MATERNAL MORBIDITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; STILLBIRTH; SYNCYTIOTROPHOBLAST; TRANSIENT ISCHEMIC ATTACK; TROPHOBLAST; FEMALE; MALE;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; MALE; PREGNANCY;

EID: 84883186376     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/159124     Document Type: Review

References (73)

1. Costedoat-Chalumeau N., Guettrot-Imbert G., Leguern V., Leroux G., Le Thi Huong D., Wechsler B., Morel N., Vauthier-Brouzes D., Dommergues M., Cornet A., Aumaître O., Pourrat O., Piette J. C., Nizard J., Pregnancy and antiphospholipid syndrome. Revue de Medecine Interne 2012 33 4 209 216 2-s2.0-84858716183 10.1016/j.revmed.2012.01.003
2. Danza A., Ruiz-Irastorza G., Khamashta M., Antiphospohlipid syndrome in obstetrics. Best Practice and Research: Clinical Obstetrics and Gynaecology 2012 26 1 65 76 2-s2.0-84856472253 10.1016/j.bpobgyn.2011.10.006
3. Miyakis S., Lockshin M. D., Atsumi T., Branch D. W., Brey R. L., Cervera R., Derkesen R. H. W. M., de Groot P. G., Koike T., Meroni P. L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P. G., Krilis S. A., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis 2006 4 2 295 306 2-s2.0-33344458573 10.1111/j.1538-7836.2006.01753.x
4. Gris J. C., Bouvier S., Molinari N., Galanaud J. P., Cochery-Nouvellon E., Mercier E., Fabbro-Peray P., Balducchi J., Marès P., Quéré I., Dauzat M., Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood 2012 119 11 2624 2632 2-s2.0-84858671114 10.1182/blood-2011-09-381913
5. Le Thi Thuong D., Tieulié N., Costedoat N., Andreu M.-., Wechsler B., Vauthier-Brouzes D., Aumaître O., Piette J. C., The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 in 15 women. Annals of the Rheumatic Diseases 2005 64 2 273 278 2-s2.0-13244298591 10.1136/ard.2003. 019000
6. Cervera R., Piette J., Font J., Khamashta M. A., Shoenfeld Y., Camps M. T., Jacobsen S., Lakos G., Tincani A., Kontopoulou-Griva I., Galeazzi M., Meroni P. L., Derksen R. H. W. M., de Groot P. G., Gromnica-Ihle E., Baleva M., Mosca M., Bombardieri S., Houssiau F., Gris J., Quéré I., Hachulla E., Vasconcelos C., Roch B., Fernández-Nebro A., Boffa M., Hughes G. R. V., Ingelmo M., Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis and Rheumatism 2002 46 4 1019 1027 2-s2.0-0036228886 10.1002/art.10187
7. Derksen R. H. W. M., de Groot P. G., The obstetric antiphospholipid syndrome. Journal of Reproductive Immunology 2008 77 1 41 50 2-s2.0-38149045141 10.1016/j.jri.2006.12.003
8. Rai R. S., Regan L., Clifford K., Pickering W., Dave M., Mackie I., McNally T., Cohen H., Antiphospholipid antibodies and β 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Human Reproduction 1995 10 8 2001 2005 2-s2.0-0029078582
9. de Groot P. G., Meijers J. C. M., β 2-Glycoprotein I: evolution, structure and function. Journal of Thrombosis and Haemostasis 2011 9 7 1275 1284 2-s2.0-79959834057 10.1111/j.1538-7836.2011.04327.x
10. de Groot P. G., Meijers J. C. M., Urbanus R. T., Recent developments in our understanding of the antiphospholipid syndrome. International Journal of Laboratory Hematology 2012 34 3 223 231 2-s2.0-84860258124 10.1111/j.1751-553X. 2012.01414.x
11. Meroni P. L., Di Simone N., Testoni C., D'Asta M., Acaia B., Caruso A., Antiphospholipid antibodies as cause of pregnancy loss. Lupus 2004 13 9 649 652 2-s2.0-4644311061 10.1191/0961203304lu2001oa
12. Harper B. E., Willis R., Pierangeli S. S., Pathophysiological mechanisms in antiphospholipid syndrome. International Journal of Clinical Rheumatology 2011 6 2 157 171 2-s2.0-79955062291 10.2217/ijr.11.9
13. Di Simone N., Di Nicuolo F., D'Ippolito S., Castellani R., Tersigni C., Caruso A., Meroni P. L., Marana R., Antiphospholipid antibodies affect human endometrial angiogenesis. Biology of Reproduction 2010 83 2 212 219 2-s2.0-77955343208 10.1095/biolreprod.110.083410
14. D'Ippolito S., Marana R., Di Nicuolo F., Castellani R., Veglia M., Stinson J., Scambia G., Di Simone N., Effect of low molecular weight heparins (LMWHs) on antiphospholipid antibodies (aPL)-mediated inhibition of endometrial angiogenesis. PLoS ONE 2012 7 1 2-s2.0-84855297285 10.1371/journal.pone.0029660 e29660
15. Branch D. W., Silver R. M., Blackwell J. L., Reading J. C., Scott J. R., Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstetrics and Gynecology 1992 80 4 614 620 2-s2.0-0026727718
16. Broder A., Putterman C., Hydroxychloroquine use is associated with lower odds of persistant positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus. Journal of Rheumatology 2013 40 1 30 33 10.3899/jrheum.120157
17. Izmirly P. M., Kim M. Y., Llanos C., Le P. U., Guerra M. M., Askanase A. D., Salmon J. E., Buyon J. P., Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Annals of the Rheumatic Diseases 2010 69 10 1827 1830 2-s2.0-77957278745 10.1136/ard.2009.119263
18. Galarza-Maldonado C., Kourilovitch M. R., Pérez-Fernández O. M., Gaybor M., Cordero C., Cabrera S., Soroka N. F., Obstetric antiphospholipid syndrome. Autoimmunity Reviews 2012 11 4 288 295 2-s2.0-84857037673 10.1016/j.autrev.2011.10.006
19. Cervera R., Khamashta M. A., Shoenfeld Y., Camps M. T., Jacobsen S., Kiss E., Zeher M. M., Tincani A., Kontopoulou-Griva I., Galeazzi M., Bellisai F., Meroni P. L., Derksen R. H. W. M., de Groot P. G., Gromnica-Ihle E., Baleva M., Mosca M., Bombardieri S., Houssiau F., Gris J., Quéré I., Hachulla E., Vasconcelos C., Roch B., Fernández-Nebro A., Piette J.-., Espinosa G., Bucciarelli S., Pisoni C. N., Bertolaccini M. L., Boffa M.-., Hughes G. R. V., Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Annals of the Rheumatic Diseases 2009 68 9 1428 1432 2-s2.0-67649371944 10.1136/ard.2008. 093179
20. Ruffatti A., Calligaro A., Hoxha A., Trevisanuto D., Ruffatti A. T., Gervasi M. T., Cuffaro S., Pengo V., Punzi L., Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care and Research 2010 62 3 302 307 2-s2.0-77649215763 10.1002/acr.20098
21. Pengo V., Banzato A., Bison E., Bracco A., Denas G., Ruffatti A., What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts? Seminars in Thrombosis and Hemostasis 2012 38 4 322 327 10.1055/s-0032-1304719
22. Nodler J., Moolamalla S. R., Ledger E. M., Nuwayhid B. S., Mulla Z. D., Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset. BMC Pregnancy and Childbirth 2009 9 article 11 2-s2.0-63849199989 10.1186/1471-2393-9-11
23. Gómez-Puerta J. A., Sanin-Blair J., Galarza-Maldonado C., Pregnancy and catastrophic antiphospholipid syndrome. Clinical Reviews in Allergy and Immunology 2009 36 2-3 85 90 2-s2.0-66349089900 10.1007/s12016-008- 8100-3
24. Buckingham K. L., Chamley L. W., A critical assessment of the role of antiphospholipid antibodies in infertility. Journal of Reproductive Immunology 2009 80 1-2 132 145 2-s2.0-67349174287 10.1016/j.jri.2008.11.005
25. Hornstein M. D., Davis O. K., Massey J. B., Paulson R. J., Collins J. A., Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertility and Sterility 2000 73 2 330 333 2-s2.0-0033978611 10.1016/S0015-0282(99)00498-7
26. Sanmarco M., Bardin N., Camoin L., Beziane A., Dignat-George F., Gamerre M., Porcu G., Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization. Annals of the New York Academy of Sciences 2007 1108 457 465 2-s2.0-34948847578 10.1196/annals.1422.048
27. Mekinian A., Lachassine E., Nicaise-Roland P., Carbillon L., Motta M., Vicaut E., Boinot C., Avcin T., Letoumelin P., de Carolis S., Rovere-Querini P., Lambert M., Derenne S., Pourrat O., Stirnemann J., Chollet-Martin S., Biasini-Rebaioli C., Rovelli R., European registry of babies born to mothers with antiphospholipid syndrome. Annals of the Rheumatic Diseases 2013 72 217 222
28. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, Centers for Disease Control and Prevention, Prevalence of Autism spectrum disorders-Autism and developmental disabilities monitoring network, 14 Sites, United States, 2008. Morbidity and Mortality Weekly Report 2012 61 3 1 19 2-s2.0-84859394070
29. Giannakopoulos B., Krilis S. A., The pathogenesis of antiphospholipid syndrome. The New England Journal of Medicine 2013 368 11 1033 1044 10.1056/NEJMra1112830
30. Evain-Brion D., Guibourdenche J., Tsatsaris V., Fournier T., Human trophoblast differentiation. Bulletin de l'Academie Nationale de Medecine 2009 193 5 1017 1025 2-s2.0-72449198179
31. Mahler M., Norman G. L., Meroni P. L., Khamashta M., Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. Autoimmunity Reviews 2012 12 2 313 317 10.1016/j.autrev.2012.05.006
32. de Groot P. G., Urbanus R. T., The significance of autoantibodies against β 2-glycoprotein I. Blood 2012 120 2 266 274 10.1182/blood-2012-03-378646
33. de Laat B., Pengo V., Pabinger I., Musial J., Voskuyl A. E., Bultink I. E. M., Ruffatti A., Rozman B., Kveder T., de Moerloose P., Boehlen F., Rand J., Ulcova-Gallova Z., Mertens K., de Groot P. G., The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. Journal of Thrombosis and Haemostasis 2009 7 11 1767 1773 2-s2.0-70449390005 10.1111/j.1538-7836.2009.03588.x
34. van Horn J. T., Craven C., Ward K., Branch D. W., Silver R. M., Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipis-like syndromes. Placenta 2004 25 7 642 648 2-s2.0-3242706212 10.1016/j.placenta.2003.12.006
35. Skrzypczak J., Jasiński P., Wirstlein P., Goździewicz T., Rajewski M., Histologic changes in placenta and chorion of women with antiphospholipid syndrome and inherited thrombophilia. Ginekologia Polska 2011 82 9 652 663 2-s2.0-80055029506
36. Shamonki J. M., Salmon J. E., Hyjek E., Baergen R. N., Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. The American Journal of Obstetrics and Gynecology 2007 196 2 167.e1 167.e5 2-s2.0-33846930928 10.1016/j.ajog.2006.10.879
37. Cavazzana I., Manuela N., Irene C., Barbara A., Sara S., Orietta B. M., Angela T., Francesco T., Luigi M. P., Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? Journal of Autoimmunity 2007 28 2-3 160 164 2-s2.0-34247571341 10.1016/j.jaut.2007.02.013
38. Gerosa M., de Angelis V., Tresoidi L., Complement involvement in antiphospholipid antibody-mediated placental damage: prospective study in APS pregnant women. Annals of the Rheumatic Diseases 2009 68 S3, article 210
39. Cohen D., Buurma A., Goemaere N. N., Girardi G., Le Cessie S., Scherjon S., Bloemenkamp K. W. M., de Heer E., Bruijn J. A., Bajema I. M., Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss. Journal of Pathology 2011 225 4 502 511 2-s2.0-79960450137 10.1002/path.2893
40. Girardi G., Berman J., Redecha P., Spruce L., Thurman J. M., Kraus D., Hollmann T. J., Casali P., Caroll M. C., Wetsel R. A., Lambris J. D., Holers V. M., Salmon J. E., Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. Journal of Clinical Investigation 2003 112 11 1644 1654 2-s2.0-0346969977 10.1172/JCI200318817
41. Kawai T., Akira S., Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011 34 5 637 650 2-s2.0-79956300649 10.1016/j.immuni.2011.05.006
42. Satta N., Kruithof E. K. O., Reber G., de Moerloose P., Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides. Molecular Immunology 2008 46 1 145 157 2-s2.0-52949139411 10.1016/j.molimm.2008.07.017
43. Dunoyer-Geindre S., de Moerloose P., Galve-de Rochemonteix B., Reber G., Kruithof E. K. O., NF B is an essential intermediate in the activation of endothelial cells by anti- β 2-glycoprotein 1 antibodies. Thrombosis and Haemostasis 2002 88 5 851 857 2-s2.0-0036847630
44. Raschi E., Testoni C., Bosisio D., Borghi M. O., Koike T., Mantovani A., Meroni P. L., Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003 101 9 3495 3500 2-s2.0-0037528699 10.1182/blood-2002-08-2349
45. Vega-Ostertag M., Casper K., Swerlick R., Ferrara D., Harris E. N., Pierangeli S. S., Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis and Rheumatism 2005 52 5 1545 1554 2-s2.0-18644361988 10.1002/art.21009
46. Satta N., Dunoyer-Geindre S., Reber G., Fish R. J., Boehlen F., Kruithof E. K. O., de Moerloose P., The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 2007 109 4 1507 1514 2-s2.0-33846899419 10.1182/blood-2005-03-024463
47. Satta N., Kruithof E. K. O., Fickentscher C., Dunoyer-Geindre S., Boehlen F., Reber G., Burger D., de Moerloose P., Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood 2011 117 20 5523 5531 2-s2.0-79956312573 10.1182/blood-2010- 11-316158
48. Poulton K., Rahman A., Giles I., Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review. Seminars in Arthritis and Rheumatism 2012 41 5 720 736 2-s2.0-84859420078 10.1016/j.semarthrit.2011.09.004
49. Prinz N., Clemens N., Strand D., Pütz I., Lorenz M., Daiber A., Stein P., Degreif A., Radsak M., Schild H., Bauer S., von Landenberg P., Lackner K. J., Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells. Blood 2011 118 8 2322 2332 2-s2.0-80052140024 10.1182/blood-2011-01-330639
50. Mulla M. J., Brosens J. J., Chamley L. W., Giles I., Pericleous C., Rahman A., Joyce S. K., Panda B., Paidas M. J., Abrahams V. M., Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. The American Journal of Reproductive Immunology 2009 62 2 96 111 2-s2.0-67650651969 10.1111/j.1600-0897.2009.00717.x
51. Meroni P. L., Gerosa M., Raschi E., Scurati S., Grossi C., Borghi M. O., Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss. Clinical Reviews in Allergy and Immunology 2008 34 3 332 337 2-s2.0-49349097758 10.1007/s12016-007-8055-9
52. Meroni P. L., Borghi M. O., Raschi E., Tedesco F., Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nature Reviews Rheumatology 2011 7 6 330 339 2-s2.0-79958086576 10.1038/nrrheum.2011.52
53. Meroni P. L., Tedesco F., Locati M., Vecchi A., Di Simone N., Acaia B., Pierangeli S. S., Borghi M. O., Anti-phospholipid antibody mediated fetal loss: Still an open question from a pathogenic point of view. Lupus 2010 19 4 453 456 2-s2.0-77951211113 10.1177/0961203309361351
54. Mulla M. J., Myrtolli K., Brosens J. J., Chamley L. W., Kwak-Kim J. Y., Paidas M. J., Abrahams V. M., Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity. The American Journal of Reproductive Immunology 2010 63 5 339 348 2-s2.0-77953039466 10.1111/j.1600-0897.2009.00805.x
55. Jovanović M., Božić M., Kovačević T., Radojčić L., Petronijević M., Vićovac L., Effects of anti-phospholipid antibodies on a human trophoblast cell line (HTR-8/SVneo). Acta Histochemica 2010 112 1 34 41 2-s2.0-73849089188 10.1016/j.acthis.2008.07. 001
56. Adler R. R., Ng A. K., Rote N. S., Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biology of Reproduction 1995 53 4 905 910 2-s2.0-0029118306 10.1095/biolreprod53.4.905
57. Di Simone N., Raschi E., Testoni C., Castellani R., D'Asta M., Shi T., Krilis S. A., Caruso A., Meroni P. L., Pathogenic role of anti- β 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β 2-glycoprotein I binding to trophoblast cells and functional effects of anti- β 2- glycoprotein I antibodies in vitro. Annals of the Rheumatic Diseases 2005 64 3 462 467 2-s2.0-14144253793 10.1136/ard.2004.021444
58. Francis J., Rai R., Sebire N. J., El-Gaddal S., Fernandes M. S., Jindal P., Lokugamage A., Regan L., Brosens J. J., Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome. Molecular Human Reproduction 2006 12 7 435 442 2-s2.0-33747871430 10.1093/molehr/gal048
59. Andreoli L., Bazzani C., Taraborelli M., Reggia R., Lojacono A., Brucato A., Meroni P. L., Tincani A., Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. Autoimmunity Reviews 2010 10 1 51 54 2-s2.0-78149357080 10.1016/j.autrev.2010.08.004
60. Bates S. M., Greer I. A., Middeldorp S., Veenstra D. L., Prabulos A., Vandvik P. O., VTE, thrombophilia, antithrombotic therapy, and pregnancy-antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012 141 2, supplement e691S e736S 2-s2.0-84856809942 10.1378/chest.11-2300
61. Bramham K., Hunt B. J., Germain S., Calatayud I., Khamashta M., Bewley S., Nelson-Piercy C., Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 2010 19 1 58 64 2-s2.0-74849134126 10.1177/0961203309347794
62. Kutteh W. H., Antiphospholipid antibodies and reproduction. Journal of Reproductive Immunology 1997 35 2 151 171 2-s2.0-0030726949 10.1016/S0165- 0378(97)00059-4
63. Nelson S. M., Greer I. A., The potential role of heparin in assisted conception. Human Reproduction Update 2008 14 6 623 645 2-s2.0-54449098367 10.1093/humupd/dmn031
64. Nishino E., Takagi T., Mitsuda N., Masuhiro K., Iwata I., Iwata M., Tanizawa O., Effect of low-dose aspirin therapy on utero-placental blood flow and malondialdehyde (MDA) as an indicator of its therapeutic effect. Acta Obstetrica et Gynaecologica Japonica 1990 42 12 1641 1647 2-s2.0-0025652559
65. Fishman P., Falach-Vaknine E., Zigelman R., Bakimer R., Sredni B., Djaldetti M., Shoenfeld Y., Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. Journal of Clinical Investigation 1993 91 4 1834 1837 2-s2.0-0027159105
66. Kwak-Kim J., Socorro L., Agcaoili M., Aleta L., Liao A., Ota K., Dambaeva S., Beaman K., Kim J. W., Gilman-Sachs A., Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome. The American Journal of Reproductive Immunology 2013 69 6 569 607 10.1111/aji.12114
67. Alijotas-Reig J., Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management. Lupus 2013 22 1 6 17
68. Comarmond C., Cacoub P., Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies. Autoimmunity Reviews 2012 12 7 752 757 10.1016/j.autrev.2012.12.006
69. Sperber K., Hom C., Chao C., Shapiro D., Ash J., Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatric Rheumatology 2009 7 article 9 2-s2.0-67449135232 10.1186/1546-0096-7-9
70. Rand J. H., Wu X., Quinn A. S., Chen P. P., Hathcock J. J., Taatjes D. J., Hydroxychloroquine directly reduces the bindin of antiphospholipid antibody- β 2-glycoprotein I complexes to phospholipid bilayers. Blood 2008 112 5 1687 1695 2-s2.0-48749104624 10.1182/blood-2008-03-144204
71. Rand J. H., Wu X. X., Quinn A. S., Ashton A. W., Chen P. P., Hathcock J. J., Andree H. A. M., Taatjes D. J., Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug. Blood 2010 115 11 2292 2299 2-s2.0-77950435764 10.1182/blood-2009-04-213520
72. Mehdi A. A., Uthman I., Khamashta M., Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future. European Journal of Clinical Investigation 2010 40 5 451 464 2-s2.0-77951213262 10.1111/j.1365-2362.2010.02281.x
73. Asherson R. A., Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. Immunobiology 2005 210 10 727 733 2-s2.0-28044458991 10.1016/j.imbio.2005.10.002